AUPH - Spark Newswire

3 minute read

The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn’s Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara

By Vandana Singh

Today, 9:08 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

APRE

7 minute read

103 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:08 PM

Gainers

AFI

2 minute read

PreMarket Prep Stock Of The Day: Good News From Aurinia Pharmaceuticals In A Down Week

By Joel Elconin

Today, 9:08 PM

Rarely mentioned in the recent chaos in the markets is the biotech sector. With a heavy emphasis in 2020 and 2021 on finding cures and treatments for COVID-19, major drug approvals from the FDA have been few and far between this year.

AUPH

5 minute read

77 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 9:08 PM

Gainers

AFRM

20 minute read

Earnings Scheduled For May 10, 2022

By Benzinga Insights

Today, 9:08 PM

Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.

ABCL

1 minute read

Earnings

Earnings Preview For Aurinia Pharmaceuticals

By Benzinga Insights

Today, 9:08 PM

Aurinia Pharmaceuticals (NASDAQ:AUPH) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Aurinia Pharmaceuticals will report an earnings per share (EPS) of $-0.27.

AUPH